Search Results for: health care

By Kuldip K. Ambastha BioNTech SE (BNTX) is aiming to become a leading biotechnology company with a main focus on individualized cancer medicine. The company has also been successful in offering an mRNA-based, two-shot coronavirus vaccine called BNT162b2 (aka: Comirnaty and Tozinameran), which has become increasingly important due to the rise of the highly contagious …

Continue reading “What Caught Our Attention in the Investment World? – Week of August 9-13, 2021”

By Kuldip K. Ambastha On Tuesday, July 20, 2021, the stock of HCA Healthcare, Inc. (HCA) was up by +14.4%. HCA Healthcare, a healthcare services company, reported strong 2Q2021 quarterly results on that trading day. Revenues, net income, and earnings all came in at impressive levels. As public health conditions have improved from the lows …

Continue reading “What Caught Our Attention in the Investment World? – Week of July 19-23, 2021”

By Kuldip K. Ambastha The stock of Teladoc Health, Inc. (TDOC), a multinational virtual healthcare and telemedicine company, dropped by -40.2% per share on Thursday, April 28, 2022. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of April 26-30, 2021; By Kuldip K. Ambastha.”) Wall Street did not …

Continue reading “What Caught Our Attention in the Investment World? – Week of April 25-29, 2022”

By Kuldip K. Ambastha The stock of GoodRx Holdings, Inc. (GDRX), a digital healthcare platform operator, dropped by -38.9% for the trading day of Tuesday, March 1, 2022. GoodRx was founded in 2011 and went public in 2020 – thus, the company’s stock has a short history of being publicly traded. The stock price dropped …

Continue reading “What Caught Our Attention in the Investment World? – Week of February 28-March 4, 2022”

By Kuldip K. Ambastha Teladoc Health, Inc. (TDOC) is a multinational virtual healthcare and telemedicine company. On Thursday, April 29, 2021, the company’s stock dropped by -8.3% for the trading day. Wall Street research analysts had expected a net loss for the latest (1Q2021) quarterly results. Teladoc surprised Wall Street research analysts by announcing a …

Continue reading “What Caught Our Attention in the Investment World? – Week of April 26-30, 2021”

By Kuldip K. Ambastha Quidel Corporation (QDEL) is an American company in the diagnostic healthcare product space. Its offerings are sold worldwide. On Friday, May 8, 2020, the company received emergency use authorization for a COVID-19 antigen test from the U.S. Food and Drug Administration. (Emergency use authorization is a new public health testing category …

Continue reading “What Caught Our Attention in the Investment World? – Week of November 9-13, 2020”

By Kuldip K. Ambastha and Anil K. Ambastha On Monday, December 9, 2019, big news emerged in the mergers & acquisitions field in terms of Merck & Co., Inc. (MRK) buying ArQule, Inc. (ARQL) and Sanofi SA (SNY) buying Synthorx Inc. (THOR). Both Merck and Sanofi bought the smaller companies to enhance their capabilities in …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 9-13, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha On October 22, 2019, Biogen Inc. (BIIB) delivered a 26.1% return for the day. This was the stock’s largest one-day percentage return in 23 years. Its Alzheimer’s drug (aducanumab) had previously been written off as a failure, but now will be getting a second chance at approval …

Continue reading “What Caught Our Attention in the Investment World? – Week of October 21-25, 2019”

By Kuldip K. Ambastha and Anil K. Ambastha Acadia Pharmaceuticals Inc. (ACAD) is a biopharmaceutical company which has Nuplazid (aka: pimavanserin) in its product pipeline. Nuplazid has been used by individuals suffering from Parkinson’s disease-linked psychosis. Acadia has now analyzed Nuplazid in relation to individuals suffering from dementia-related psychosis. Currently, no approved drugs exist in …

Continue reading “What Caught Our Attention in the Investment World? – Week of September 9-13, 2019”